BlackRock UK Equity D AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -4.1 | 14.9 | -5.7 | 12.6 | 7.5 | |
+/-Cat | 5.0 | -3.0 | -3.6 | 4.4 | 0.2 | |
+/-B’mrk | - | - | - | 4.9 | -0.7 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 20/11/2024 | GBX 10037.14 | |
Day Change | 0.16% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00B410CR74 | |
Fund Size (Mil) 31/10/2024 | GBP 334.74 | |
Share Class Size (Mil) - | - | |
Max Initial Charge | - | |
Ongoing Charge 09/02/2024 | 0.91% |
Investment Objective: BlackRock UK Equity D Acc |
The aim of the Fund is to deliver a return on your investment (generated through an increase to the value of the assets held by the Fund and/or income received from those assets). In order to achieve its investment objective, the Fund will invest at least 80% of its total assets in equities (i.e. shares) of companies located in, or exercising a significant part of their economic activity across all economic sectors in the United Kingdom. The Fund has the flexibility to invest up to 20% of its total assets outside of these parameters, including in other countries globally. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Adam Avigdori 01/12/2022 | ||
Samantha Brownlee 01/12/2022 | ||
Click here to see others | ||
Inception Date 22/07/2011 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock UK Equity D Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 7.26 |
RELX PLC | Industrials | 7.04 |
Shell PLC | Energy | 6.10 |
Compass Group PLC | Consumer Cyclical | 5.41 |
3i Group Ord | 4.99 | |
Increase Decrease New since last portfolio | ||
BlackRock UK Equity D Acc |